Loading patent…
AssigneesServicio Andaluz De Salud, Instituto Mediterráneo Para El Avance De La Biotecnología Y La Investigación Sanitaria (Fundac
InventorsMaría Yolanda De Diego Otero, Lucia María Pérez Costillas, Ignacio Del Arco Herrera
Estimating the term…
The invention relates to the use of antioxidants such as, ascorbic acid (Vitamin C), Tocopherol (Vitamin E), vitamin A and polyphenols, for the treatment of cognitive and behavioural disorders in patients with Fragile X syndrome. Specifically, the invention relates to the use of said antioxidants in a pre-determined concentration in a therapeutic doses, in order to obtain the greatest amount of antioxidants possible in all the tissues of the organism, so as to eliminate the excess free radicals produced in the cells and to treat the aforementioned cognitive and behavioural disorders in patients with Fragile X syndrome.
1-21. (canceled)
A method of treating a mammal suffering from Fragile X Syndrome, the method comprising administering to said mammal a therapeutically effective amount of a pharmaceutical composition or a combined preparation comprising:
Dependencies are inferred from the claim text.